PER
Click for more information
3.57% 8.1¢ percheron therapeutics limited

Ann: ATL1102 Revised Plans accelerate reporting of unblinded data, page-22

  1. MSpark
    89 Posts.
    lightbulb Created with Sketch. 43
    clock Created with Sketch.
    07/09/22
    10:19
    Post #: 63559864
    R&D rebates are 50% of the total cost.
    ANP Price at posting: 11.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

GWR Scoping study and Phase 2 drilling progress Prospect Ridge magnesium play for GWR
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢ 		Change
-0.003(3.57%) 		Mkt cap ! $75.73M
Open High Low Value Volume
8.2¢ 8.2¢ 8.1¢ $16.49K 202.4K

Buyers (Bids)

No. Vol. Price($)
2 51557 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 169 1
View Market Depth
Last trade - 12.01pm 26/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.